EP1381644A2 - Antimicrobial rubber compositions - Google Patents

Antimicrobial rubber compositions

Info

Publication number
EP1381644A2
EP1381644A2 EP02753761A EP02753761A EP1381644A2 EP 1381644 A2 EP1381644 A2 EP 1381644A2 EP 02753761 A EP02753761 A EP 02753761A EP 02753761 A EP02753761 A EP 02753761A EP 1381644 A2 EP1381644 A2 EP 1381644A2
Authority
EP
European Patent Office
Prior art keywords
rubber
silver
article
formulation
antimicrobial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02753761A
Other languages
German (de)
French (fr)
Other versions
EP1381644A4 (en
Inventor
John G. Lever
Geoffrey R. Haas
Bhawan Patel
William O. Burke Iii
Robert C. Kerr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Milliken and Co
Original Assignee
Milliken and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/815,730 external-priority patent/US6455610B1/en
Priority claimed from US09/815,637 external-priority patent/US6448306B1/en
Priority claimed from US09/815,483 external-priority patent/US6555599B2/en
Application filed by Milliken and Co filed Critical Milliken and Co
Publication of EP1381644A2 publication Critical patent/EP1381644A2/en
Publication of EP1381644A4 publication Critical patent/EP1381644A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/06Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/01Use of inorganic substances as compounding ingredients characterized by their specific function
    • C08K3/015Biocides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/0008Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0058Biocides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/14Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104Silver, e.g. silver sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow

Abstract

Certain non-silicone pre-vulcanized and/or vulcanized raw rubber formulations that include silver-based compounds to provide highly desirable long-term antimicrobial characteristics (or within the ultimate cured rubber articles made therefrom such pre-vulcanized formulations) are provided. Such formulations are intended to be vulcanized to provide solid or blown (foam or sponge) rubber articles which can be utilized in a variety of different applications (as well as multi-layered composites) including such antimicrobial rubber. As silver-based compounds are deleteriously affected by utilization of standard curing agents and curing accelerators, such as sulfur-based compounds and/or systems, the ability to provide such an effective antimicrobial vulcanized rubber article is rather difficult. However, this invention encompasses the presence of different non-sulfur-based curing systems and curing agents, such as inorganic and organic peroxides and oxides, as some examples, that permit vulcanization and do not irreversibly bind silver ions thereto, thereby resulting in long-term antimicrobial performance of the ultimate rubber article itself. The raw or cured rubber formulations may also comprise fillers and may also include plasticizers to provide desired characteristics of dimensional stability, stiffness, flexural modulus, tensile strength, abrasion resistance, elongation, and the like, for the ultimate rubber article, while simultaneously and surprisingly enhancing the control of antimicrobial efficacy in the rubber article as well.

Description

ANTIMICROBIAL RUBBER COMPOSITIONS
Field of the Invention
This invention relates to certain non-silicone pre-vulcanized and/or vulcanized raw rubber formulations that include silver-based compounds to provide highly desirable long- term antimicrobial characteristics (or within the ultimate cured rubber articles made therefrom such pre-vulcanized formulations). Such formulations are intended to be vulcanized to provide solid or blown (foam or sponge) rubber articles which can be utilized in a variety of different applications (as well as multi-layered composites) including such antimicrobial rubber. As silver-based compounds are deleteriously affected by utilization of standard curing agents and curing accelerators, such as sulfur-based compounds and/or systems, the ability to provide such an effective antimicrobial vulcanized rubber article is rather difficult. However, this invention encompasses the presence of different non-sulfur-based curing systems and curing agents, such as inorganic and organic peroxides and oxides, as some examples, that permit vulcanization and do not irreversibly bind silver ions thereto, thereby resulting in long-term antimicrobial performance of the ultimate rubber article itself. The raw or cured rubber formulations may also comprise fillers and may also include plasticizers to provide desired characteristics of dimensional stability, stiffness, flexural modulus, tensile strength, abrasion resistance, elongation, and the like, for the ultimate rubber article, while simultaneously and surprisingly enlmncing the control of antimicrobial efficacy in the rubber article as well.
Discussion of the Prior Art
All U.S. Patents listed below are herein entirely incorporated by reference. There has been a great deal of attention in recent years given to the hazards of microbial contamination from potential everyday exposure. Noteworthy examples of such concerns include the fatal consequences of food poisoning due to certain strains of Eschericia coli being found within undercooked beef in fast food restaurants; Salmonella enteritidis contamination causing sicknesses from undercooked and unwashed poultry food products; and illnesses and skin infections attributed to Staphylococcus aureus, Klebsiella pneumoniae, yeast (Candida albicans), and other unicellular organisms. With such an increased consumer interest in this area, manufacturers have begun introducing antimicrobial agents within various everyday products and articles. For instance, certain brands of cutting boards, , shoe inserts, medical devices and implements, liquid soaps, etc., often contain antimicrobial compounds. The most popular antimicrobial agent for such articles is triclosan. Although the incorporation of such a compound within a liquid or certain polymeric media has been achieved, other substrates, specifically vulcanized rubber and surfaces thereof, have proven less accessible. For instance, triclosan itself diffuses easily within and out of polymeric substrates and/or matrices,and thus is not very durable. Furthermore, triclosan lacks the desired thermal stability for plastic processing at high temperatures, and does not provide a wide range of bacterial kill. For instance, triclosan does not exhibit any kill for Pseudomonas , aeruginosa.
Antimicrobial raw rubber formulations are certainly highly desired for the production of vulcanized rubber articles to provide not only antibacterial benefits, but also antifungal, antimildew, antistaining, and odor control properties. Rubber articles are utilized in many different applications, including automobiles (hoses, tires, bumpers, etc.), food processing equipment (conveyor belts, wheels, tubing, gaskets), household items (toys, sink washers, gaskets, appliances, rubber door mats, rubber floor mats, carpeted floor or door mats, gloves, and the like), basically any rubber applications in which bacterial and fungal growth is a potential problem. There thus remains a long-felt need to provide an effective, durable, reliable antimicrobial vulcanized rubber formulation which will provide such long-term antimicrobial and/or antifungal effects within the final vulcanized rubber article.
Unfortunately, such a highly desired antimicrobial raw rubber formulation and/or vulcanized rubber article comprising silver-based antimicrobial agents has heretofore not been provided by the pertinent prior art.
The closest art includes Japanese Patent Application 1997-342076 which discloses the production of unvulcanized rubber formulations and articles exhibiting antibacterial properties due to the presence of silver complexes. Such formulations are formed through high temperature kneading in an oxygen-free atmosphere and are used as parts in a water disinfection system. Again, no vulcanized rubber is taught or obtained within or through this disclosure. Antimicrobial rubber bands have been taught in Japanese Patent Application 1997-140034 in vulcanized form with silver antimicrobials therein. However, such compounds are rather limited in use and the vulcanization step must include a sulfur curing agent to effectuate the final vulcanized arrangement of the subject rubber. Such sulfur curing agents have a remarkably deleterious effect on certain silver-based antimicrobials such that the sulfur reacts with the silver ion, to form silver sulfide, thus rendering it ineffective as a bactericide. As such, the utilization of such specific rubber band formulations for and within large-scale antimicrobial articles is basically unworkable. Certain types of antimicrobial peroxide-catalyst vulcanized rubber formulations have been produced in the past; however, such peroxide-cured rubbers are all silicone-based. It is well understood and accepted that silicone rubbers cannot be vulcanized by typical sulfur- based catalysts. Thus, the antimicrobial rubber formulations of Japanese Patent Applications 1997-026273 and 1995-065149 as well as U.S. Pat. No. 5,466,726 are standard vulcanized silicone rubber formulations and articles which also include certain antimicrobial compounds. Furthermore, rubber latexes (non-vulcanized) comprising antimicrobials have been disclosed (U.S. Pat. No. 5,736,591, for example), as have floor mats having silver-based antimicrobials incoiporated within pile fiber components and which have non-antimicrobial rubber backings cured through peroxide-catalyzed vulcanization to protect the pile fiber antimicrobial compounds from attack by any sulfur compounds (as in Japanese Patent
Applications 1993-3555168 and 1995-38991). Again, however, to date there have been no disclosures or suggestions of producing a non-silicone raw rubber formulation or vulcanized rubber article made therefrom exhibiting excellent antimicrobial properties through the long- term effective utilization of silver-based antibacterial compounds. This invention fills such a void.
Object of the Invention
It is therefore an object of this invention to provide an antimicrobial substantially non- silicone pre-vulcanized raw rubber formulation that ultimately provides an inventive vulcanized non-silicone rubber article of sufficient antimicrobial activity and structural integrity to withstand repeated use without losing an appreciable level of either antimicrobial efficiency or modulus strength. Another object of the invention is to ultimately provide an antimicrobial non-silicone pre-vulcanized rubber formulation comprising silver-based antimicrobial compounds which include curing agents and curing accelerators which do not deleteriously effect the antimicrobial activity of the ultimate vulcanized rubber article (and thus is essentially free from sulfur-based curing agents and accelerators). Yet another object of this invention is to provide an unvulcanized non-silicone raw rubber formulation that, upon vulcanization, cures to form such an inventive antimicrobial non-silicone vulcanized rubber article exhibiting log kill rates for Staphylococcus aureus and Klebsiella pneumoniae (and/or other types of bacteria as well) of at least 1.0 after 24 hours exposure at room temperature. Still another object of the invention is to provide an unvulcanized rubber formulation that, upon vulcanization, cures to form an antifungal article exhibiting at least 70% inhibition in accordance with Test Method ISO 486, of Aspergillus niger, Paecilomyces variotii, and Trichoderma virens (and/or other types of fungi as well) for at least 15 days at 30°C and at greater than 90% humidity. Still another object of this invention is to provide an unvulcanized non-silicone raw rubber formulation comprising structural integrity filler components (e.g., carbon black, silica, metal salts, organic salts, metal oxides, and the like) and plasticizers (e.g., phthalate oil, paraffinic oil, and the like) that provide enhancements in the control of antimicrobial efficacy of such a rubber article through controlled silver ion release to the article surface. Still another object of the invention is to provide a finished article that exhibits increases in antimicrobial activity after industrial washing and/or abrasion. Still another object of this invention to provide an antimicrobial dimensionally stable vulcanized rubber article (comprising, for example, EPDM, NBR, or natural rubber) exhibiting sufficient antimicrobial activity and structural integrity to withstand repeated use without losing an appreciable level of either antimicrobial power or modulus strength. Another object of the invention is to provide an antimicrobial vulcanized EPDM, NBR, or natural rubber article comprising silver-based antimicrobial compounds which include curing agents which do not deleteriously effect the antimicrobial activity of the finished vulcanized EPDM, NBR, or natural article (and thus is essentially free from sulfur-based curing agents and accelerators). Yet another object of this invention is to provide a vulcanized EPDM rubber-containing article that exhibits log kill rates for Staphylococcus aureus and Klebsiella pneumoniae (and/or other types of bacteria as well) of at least 1.0 after 24 hours exposure at room temperature as well as prevention of growth of certain fungi after at least 15 days of exposure. Still another object of this invention is to provide a vulcanized EPDM, NBR, or natural rubber-containing article comprising structural integrity filler components and plasticizers (such as silica, metal salts, organic salts, pigments, such as carbon black, calcium carbonate, paraffinic oils, phthalate oils, metal oxides, and the like) that also provide enhancements in the control of antimicrobial efficacy of the article itself through regulated silver ion release to the article surface (e.g., exhibits higher log kill rates for Staphylococcus aureus and Klebsiella pneumoniae and prevention of growth of fungi such as Aspergillus niger). Still another object of the invention is to provide a finished article that exhibits increases in antimicrobial activity after industrial washing and/or abrasion. Yet another object is to provide a simple method of producing such an atimicrobial vulcanized EPDM, NBR, or natural rubber-containing article.
Accordingly, this invention encompasses a non-silicone unvulcanized raw rubber formulation comprising at least one rubber constituent, at least one silver-based antimicrobial compound, and at least one curing catalyst compound, wherein said catalyst does not include an appreciable amount of sulfur-based curing agent and/or accelerator compound or compounds, and wherein said rubber formulation optionally comprises a blowing agent, and at least one filler component. Such a raw rubber formulation can be subsequently cured (vulcanized) in the presence of the substantially non-sulfur based curing agents to produce a resilient antimicrobially effective rubber article that exhibits dimensional stability. This invention further encompasses a dimensionally stable vulcanized rubber-containing article exhibiting log kill rates for Staphylococcus aureus and Klebsiella pneumoniae of at least 1.0 each after 24 hours exposure at room temperature (such as EPDM, NBR, and/or natural rubber-based). Also, this invention encompasses a dimensionally stable vulcanized rubber- containing article exhibiting antifungal properties such that said article exhibits at least 70% inhibition in accordance with Test Method ISO 486, of Aspergillus niger ATCC 6275 for at least 15 days at 30°C and at greater than 90% humidity. Furthermore this invention encompasses such a vulcanized rubber-containing article comprising at least one silver ion control release additive, such as those selected selected from the group consisting of fillers (such as carbon black, calcium carbonate, inorganic salts, organic salts, silica, and mixtures thereof) and plasticizers (oils such as phthalate oils and paraffinic oils). Additionally, this invention encompasses a method of producing a vulcanized rubber-containing article comprising the steps of providing a rubber formulation comprising uncured rubber, at least one non-sulfur based curing agent, and at least one silver-based antimicrobial compound, and vulcanizing said rubber formulation at a temperature of at least 150°C and at least at a pressure of 3 bars, wherein said rubber formulation is substantially free from sulfur curing agent and accelerator.
The term "dimensionally stable" is intended to encompass a vulcanized rubber article that is structurally able to be handled without disintegrating into smaller portions. Thus, the article must exhibit some degree of structural integrity and, being a rubber, a certain degree of flexural modulus.
Such a specific antimicrobial non-silicone raw or cured rubber formulation has not been taught nor fairly suggested within the rubber industry or prior art. As noted above, the avoidance of sulfur-based curing agents and accelerators to any appreciable degree thus permits the retention of silver antimicrobials within the final product in amounts sufficient to provide long-lasting log kill rates for Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Eschericia coli, at the very least. Furthermore, due primarily to high costs, non-sulfur curing agents have not been prevalent within vulcanized rubber formulations and articles. As such, there has been no teaching or fair suggestion of coupling non-sulfur curing agents (and most preferably peroxide curing agents) with silver-based antimicrobial agents within pre-vulcanized rubber formulations to form effectively antimicrobial vulcanized rubber articles.
Additionally, generally and preferably, though not necessarily, certain fillers and oils (such as silica, carbon black, stearates as fillers, and phthalate and paraffinic oils) are required to provide both flexural modulus and structural integrity to vulcanized rubber articles. The rubber component alone generally does not exhibit proper dimensional stability without such additives. Surprisingly, the presence of such additives also provides the ability to control silver-ion release at the target article surface. Without intending to be bound to any specific scientific theory, it appears that such fillers as silica and such oils as paraffinic oil (as some examples), act in such a way as to draw moisture into the article which then transports silver ions from within the article to the surface. In such a situation, then, the rubber article may exhibit enhanced silver release resulting in higher log kill rates for certain bacteria due to the presence of larger amounts of available surface silver ions. Other fillers, such as pigments (for example, carbon black) and calcium carbonate (as some examples) appear to work in the opposite manner by keeping water out of the target article and thus prevent silver-ion migration to the article surface. Thus, the reduction of such silver-ion availability increases the long term durability of the antimicrobial article. In effect, then, the actual antibacterial efficacy of the entire rubber article can be controlled through the presence of certain amounts of such generally required fillers and oils (some hydrophilic antistatic agents also appear to act in the same manner as silica as well). As a result, the necessary filler and/or oil constituents required to provide dimensional resiliency and/or flexural modulus (and thus actual usefulness) of the finished article serve a dual purpose heretofore unrecognized within the rubber industry. Rubber articles can be produced with specific end-uses in mind depending upon the duration of antimicrobial activity desired through the addition of specific amounts of such additives. Again, such a targeted duration antimicrobial vulcanized article and the benefits thereof have heretofore been unknown and unrecognized within the rubber industry. These rubber components are thus hereinafter referred to as "silver ion release control additives".
The term rubber, as noted above, is intended to cover any standard rubber which must be vulcanized to provide a dimensionally stable rubber article. The specific types are listed below and have been utilized for many years and are generally well known and taught throughout the prior art. Such inventive rubber formulations should also possess a chemical plasticizer which aids in the breakdown period of the elastomer during compounding and processing (and provides flexural modulus properties to the finished article) as well as fillers required for reinforcement (e.g. calcium carbonate, carbon black, silica, and clays). Optionally, to form a blown (foam or sponge, closed-cell, for example) rubber type, a blowing agent may be added to the inventive formulation.
The rubber component or components of the inventive raw or cured rubber formulation is therefore selected from the group consisting of nitrile rubber [such as acrylonitrile-butadiene (NBR)], styrene-butadiene rubber (SBR), chloroprene, ethylene propylene diene comonomer (EPDM), natural rubber, polyurethane rubber, butyl rubbers, neoprene, isoprene, halobutyl rubbers, fluoroelastomers, epichlorohydrin rubber, polyacrylate rubber, and chlorinated polyethylene rubber. Modified rubbers which are potentially useful, though more expensive, include hydrogenated SBR, hydrogenated NBR, and carboxylated NBR and the like. Although the presence of silicone-rubber is discouraged within the inventive formulation, there remains the possibility of adding certain low amounts of such specific unvulcanized rubber components without adversely affecting the overall antimicrobial rubber formulation itself. Thus, up to 25% by total weight of the formulation may be silicone-rubber; however, the vast majority of the rubber formulation must be non- silicone rubber. Furthermore, the non-silicone rubber portion must not possess an appreciable amount of sulfur-based curing agent or residue (in the finished article) and thus must be vulcanized through curing with primarily non-sulfur-based compounds (such as peroxides and metal oxides, for example). The rubber component is present in amount of from about 10 to about 1,000 parts of the entire composition, more preferably from about 50 to about 500 parts, and most preferably from about 100 to about 200 parts. Thus, with a total number of parts between about 300 and 2,000 parts throughout the target pre-vulcanized rubber formulation (and subsequently formed rubber article), the rubber constitutes from about 25 to about 70% of the percentage by parts of the entire formulation (and article). The remainder comprises additives such as fillers, oils, curing agents, the desired antimicrobial agents, optional blowing agents, and the like (as discussed more thoroughly below).
Furthermore, the non-silicone rubber portion must not possess an appreciable amount of sulfur-based curing agent or residue (in the finished article) and thus must be vulcanized through curing with primarily non-sulfur-based compounds (such as peroxides and metal oxides, for example). The rubber component is present in amount of from about 10 to about 1,000 parts of the entire composition, more preferably from about 50 to about 500 parts, and most preferably from about 100 to about 200 parts.
The antimicrobial agent of the inventive raw or cured rubber formulation may be of any standard silver-based compounds. Such compounds, in contrast with organic types, such as triclosan, for example, do not exhibit low thermal stability and thus remain within the target matrix or substrate at different temperatures. Thus, such an antimicrobial is more easily controlled, as discussed above, for surface release as desired. Such agents include, without limitation, silver salts, silver oxides, elemental silver, and, most preferably ion exchange, glass, and/or zeolite compounds. Of even greater preference are silver-based ion exchange compounds for this purpose due to the low levels of discoloration and enhanced durability in the final product provided by such compounds, the efficacy provided to the final formulation with such a compound, and the ease of manufacture permitted with such specific compounds. Thus, the antimicrobial agent of this invention may be any type which imparts the desired log kill rates as previously discussed to Staphylococcus aureus, Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa, as merely representative organisms. Furthermore, such antimicrobial compounds must be able to withstand elevated processing temperatures for successful incorporation within the target non-sulfur (peroxide, for example) inventive cured rubber formulations. Again, such antimicrobial agents comprise, preferably, silver-containing ion exchange, glass, and/or zeolite compounds. Most preferably, such a compound is a silver-based ion-exchange compound and particularly does not include any added organic bactericide compounds (thereby not permitting a release of volatile organic compounds into the atmosphere during processing at high temperatures, etc.). The preferred silver-based ion exchange material is an antimicrobial silver zirconium phosphate available from Milliken & Company, under the trade name ALPHAS AN®. Such compounds are available in different silver ion concentrations as well as mixtures with zinc oxide. Thus, different compounds of from about 0.01 to 10% of silver ion concentration, preferably from about 3 to about 8%„ and most preferably amounts of about 3, 3.8, and 10% by total amount of components (e.g. of the total amount of silver ions and zirconium phosphate) are possible. Other potentially preferred silver-containing solid inorganic antimicrobials in this invention are silver-substituted zeolite available from Sinanen under the tradename ZEOMIC®, or a silver-substituted glass available from Ishizuka Glass under the tradename IONPURE®, which may be utilized either in addition to or as a substitute for the preferred species. Other possible compounds, again without limitation, are silver-based materials such as MICROFREE®, available from DuPont, as well as JMAC®, available from Johnson Mathey. Generally, such an antimicrobial compound is added to a rubber formulation in an amount of from about 0.1 to 10% by total weight of the particular total rubber formulation; preferably from about 0.1 to about 5%; more preferably from about 0.1 to about 2%; and most preferably from about 0.2 to about 2%.
Furthermore, with regard to silver-based inorganic antimicrobial materials, these particular antimicrobial rubber articles are shown to be particularly suitable for the desired r high levels of efficacy and durability required of such articles. It has been found that certain silver-based ion exchange compounds, such as ALPHASAN® brand antimicrobials available from Milliken & Company, (U.S. Patent 5926238, U.S. Patent 5441717, U.S. Patent 5698229 to Toagosei Chemical Industry Inc.), exhibit impressive bio-efficacy. After a period of time, alternative antimicrobial compounds (e.g. triclosan, Microchek, OBPA, Zn-omadine) initially suffer from decomposition under the high processing temperatures, followed by depletion of the biocide through leaching into the surrounding environment and finally through depleted bactericidal activity. However, silver-containing ion exchange, glass, and/or zeolite compounds do not suffer from these shortcomings. Such antimicrobial agents exhibit high temperature stability (>1000°C), do not leach into the environment and provide substantial amounts of the oligodynamic silver ion to provide for the desired extensive durability. The inventive antimicrobial articles ultimately made from the inventive raw rubber formulations should exhibit an acceptable log kill rate after 24 hours in accordance with at least one method of either the AATCC Draft Method entitled "Assessment of Antimicrobial Properties on Hydrophobic Textiles and Solid Substrates" or Japanese Method JIS2 2801. Such an acceptable level log kill rate is tested for Staphylococcus aureus or Klebsiella pneumoniae of at least 0.1 increase over baseline. Alternatively, an acceptable level will exist if the log kill rate is greater than the log kill rate for non-treated (i.e., no solid inorganic antimicrobial added) rubber articles (such as about 0.5 log kill rate increase over control, antimicrobial-free rubbers). Preferably these log kill rate baseline increases are at least 0.3 and 0.3, respectively for S. aureus and K. pneumoniae; more preferably these log kill rates are 0.5 and 0.5, respectively; and most preferably these are 1.0 and 1.0, respectively. Of course, the high end of such log kill rates are much higher than the baseline, on the magnitude of 5.0 (99.999% kill rate). Any rate in between is thus, of course, acceptable as well. However, log kill rates which are negative in number are also acceptable for this invention as long as such measurements are better than that recorded for correlated non-treated rubber articles. In such an instance, the antimicrobial material present within the rubber article at least exhibits a hindrance to microbial growth. Furthermore, such rubber articles should exhibit log kill rates of the same degree for other types of bacteria, such as, Psedumonas aeruginosa and Eschericia coli. Of great surprise within this invention is the ability for the inventive finished articles made from the inventive raw rubber formulations to provide antifungal benefits as well as antibacterial characteristics. Such versatility is rare among antibacterial compounds; however, without intending to be limited to any particular scientific theory, it appears that the silver ions, and particularly the silver ions present at the article surface in great abundance, provide excellent antifungal properties, at least for certain fungi. Thus, another embodiment of this inventive rubber formulation should provide fungal kill durability of at least 15 sequential days for such organisms as Aspergillus niger and mixtures of fungi including Aspergillus niger ATCC 6275, Paecilomyces variotii ATCC 18502, Trichoderma virens ATCC 9645. In order to provide a greater array of potential antifungal benefits, other compounds may be incorporated within the target pre-vulcanized rubber formulation (and subsequent article), such as zinc oxide, as one example. Of great importance to the effectiveness of the inventive formulation in terms of antimicrobial and antifungal activity is the omission of deleterious amounts of sulfur-based curing agents and accelerators from the inventive raw rubber formulation (and thus the vulcanized article). As noted above, sulfur reacts with the preferred silver-based antimicrobials and irreversibly binds the silver ions (as silver sulfides, for example) within the rubber composition and/or article itself. As such, the resultant silver sulfides, etc., are ineffective as antimicrobial agents and their presence thus renders the final product antimicrobially inactive. Thus, it has been necessary to produce a vulcanized rubber article lacking any appreciable amount of sulfur curing agents and accelerators therein. It should be appreciated that the term "appreciable amount" permits a small amount to be present. It has been found that, as a molar ratio, a 1:1 ratio (and above) between sulfur molar presence and silver molar presence results in a clear loss of antimicrobial activity within the desired ultimate vulcanized article. However, greater molar amounts of silver in relation to sulfur provide at least some antimicrobial properties to the desired article. A molar ratio range of from 0.25:1 to about 0.000000001:1 of sulfur to silver ions is thus at least acceptable. The primary curing agent, however, must be of non-sulfur nature (and is preferably, though not necessarily) a peroxide-based compound in order to provide the desired antimicrobial activity for the subject rubber. Although peroxide curing agents have been utilized for vulcanization of rubber previously, such a different type of curing agent is not widely utilized as a suitable vulcanization catalyst for rubber for a number of reasons. Foremost, such curing agents are much more costly than standard sulfur-based agents and thus the utilization of such peroxides, and the like, as a replacement for the sulfur-based compounds have been rather limited to mostly silicone-based rubbers or, at the very least, non-antibacterial rubber articles. However, due to the problems associated with antimicrobial activity when such compounds are reacted with sulfur-based curing agents, alternatives to such sulfur-based cured articles was to permit utilization of such effective antimicrobial compounds within raw and vulcanized rubber for long-term high log kill rate effects. Thus, although non-sulfur-based compounds are not readily utilized within the non-silicone industry as vulcanization curing agents, utilization of such curing agents was necessary to provide an effective, ultimate antimicrobial vulcanized rubber article.
Surprisingly, it has now been found that the inventive rubber formulations (either in raw or cured form) listed above are available without such sulfur-based curing agents in any appreciable amounts; most importantly, with the introduction of certain additives, the structural integrity of the rubber formulation is improved to an acceptable level and the efficacy of the antimicrobial components can be controlled simultaneously.
Thus, the curing agent present within the inventive raw unvulcanized rubber formulation must be at least a majority, and preferably at least about 75% by weight of a non- sulfur-based curing agent. As discussed above, traditional sulfur and sulfur-based catalysts will not work with the inventive antimicrobial formulations due to chemical reactions between the sulfur atoms and and the biocidal Ag+ ion. However, non-sulfur-based catalysts, such as, for example, and without intending to being limited to peroxides, certain compounds provide effective curing for the inventive raw rubber formulations, such as organic peroxides, including dicumyl peroxide, 2,5-bis(t-butylperoxy)-2.5-dimethylhexane, di-(t-butyl-peroxy- isopropyl) benzene, di-(t-butyl-peroxy-trimethyl)-cyclohexane, and the like, and inorganic oxides andor peroxides, including zinc oxide, zinc peroxide, and the like. Such a curing agent should be present in amount of from about 0.5 to about 100 parts per hundred parts of rubber (pphr); more preferably from about 1 to about 50 pphr; and most preferably from about 2 to about 10 pphr, all either as one curing agent alone, or as the combination of any number of different types.
Other additives to the rubber fonnulation include any of the aforementioned silver ion release control additives, as well as accelerators, accelerator activators, antidegradants, softeners, abrasives, colorants, flame retardants, homogenizing agents, internal lubricants, and deodorants. Such components should be present, if at all, in rather low amounts, of from about 0.1 to about 100 pphr.
It has further been unexpectedly determined that a substantial increase in the antibacterial and antifungal efficacy is provided upon washing the finished article. Abrading the surface of such an article also permits increases in such characteristics; however, industrial laundering of certain rubber products (mats, and the like) can be improved in antimicrobial, etc., efficacy through a simple washing. In fact, such an increase steadily improves with greater numbers of consistent washes such that it has been found that a rubber article as first vulcanized exhibits lower overall antibacterial and antifungal activity than one that has been washed one, two, three, and up to at least 20 times (in a standard industrial rotary washing machine). Such a surprising benefit thus permits utilization of such rubber articles as floor coverings (mats, as one example, such as those with carpeted portions or those which are rubber alone; particularly foamed rubber mats for antifatigue properties and reduced specific gravity so as to reduce the chances of machinery damage during such industrial rotaiy launderings and dryings), and other articles which can be easily washed within standard laundry machines. Furthermore, as alluded to above, friction with the subject rubber article surface can remove very slight layers of rubber from the article surface thereby permitting "fresh" silver- comprising crystallites to the surface to act as desired in their antibacterial and/or antifungal capacities. Basically, then, the inventive article produced from the inventive raw rubber formulation exhibits an even dispersion of antimicrobial particles throughout the entire rubber article. Such an even dispersion of the biocide throughout the rubber article thus provides a reservoir of fresh crystallites containing the biocidal metallic ion. As layers of the rubber are worn and abraded away, antimicrobial particles containing untapped silver ions become available.
The preferred inventive peroxide-cured rubber articles made from the inventive raw rubber formulations containing the antimicrobial agent can be processed into rubber articles which exhibit excellent antimicrobial qualities as well as antimicrobial efficiency throughout the rubber article's lifetime. Examples of other such rubber articles encompassed within this invention include, but are not limited to hard rubber mats, static dissipative rubber mats, anti- fatigue rubber mats, rubber mats which include a face fiber, rubber link mats, rubber gaskets, rubber medical goods, rubber containing bandages, medical devices, conveyor belts, rubber gloves, rubber belts and rubber wheels used in food processing, rubber clothing, rubber shoes, rubber boots, rubber tubing, and rubber automotive fuel hoses. Such inventive formulations may also be incorporated into a multilayered rubber article in which the antimicrobial agent can be incorporated into any surface layer and still provide the desired antimicrobial efficiency.
Of particular interest is the formation of multilayered rubber articles wherein at least one of such rubber layer exhibits the desired antimicrobial activity and thus is made from an inventive raw rubber formulation. Such layered articles may be adhered together through co- vulcanization, gluing, and the like. Furthermore, layers of other types of materials may be placed being rubber layers as well to provide, as one non-limiting property, better structural stability to the desired multilayered article. The non-limiting preferred embodiments of these rubber formulations are discussed in greater detail below.
Description of the Preferred Embodiments hiventive Raw Rubber Formulations: (pphr=parts per hundred rubber)
(INVENTIVE) EPDM BASE FORMULATION 1
Component Amount Ethylene-propylene diene modified Rubber (Nordel IP from DuPont-Dow) 100 parts
Pentaerythritol tetrastearate (processing aid) 2 pphr '
FEF N550 (CABOT carbon black filler) 100 pphr
Silica 50 pphr
Stearic acid 0.5 pplrr Zinc oxide 5 pphr
Calcium carbonate 50 pphr
Paraffinic oil 50 pphr
Ethyleneglycol dimethacrylate 2.5 pphr di-(tert-butyl-peroxy-isopropyl)benzene 4 pphr di-(tert-butyl-peroxy-trimethyl)-cyclohexane 4 pphr
Antimicrobial as noted
(INVENTIVE) EPDM BASE FORMULATION 2
Component Amount
Ethylene-propylene diene modified Rubber 100 parts di-(tert-butyl-peroxy-isopropyl)benzene 4 pphr di-(tert-butyl-peroxy-trimethyl)-cyclohexane 4 pphr
Antimicrobial as noted
(INVENTIVE) EPDM BASE FORMULATION 3
Component Amount
Ethylene-propylene diene modified Rubber 100 parts
FEF N550 (CABOT carbon black filler) 100 pphr Paraffinic oil 50 pphr di-(tert-butyl-peroxy-isopropyl)benzene 4 pphr di-(te7"t-butyl-peroxy-trimethyl)-cyclohexane 4 pphr
Antimicrobial as noted
(INVENTIVE) EPDM BASE FORMULATION 4
Component Amount
Ethylene-propylene diene modified Rubber (from DuPont-Dow) 100 parts Silica 50 pphr
Paraffinic oil 50 pphr di-(tert-butyl-peroxy-isopropyl)benzene 4 pphr di-(tert-butyl-peroxy-trimethyl)-cyclohexane 4 pphr
Antimicrobial as noted (INVENTIVE) EPDM BASE FORMULATION 5
Component Amount
Ethylene-propylene diene modified Rubber 100 parts Pentaerythritol tetrastearate (processing aid) 2 pphr
Silica 50 pphr
Stearic acid 0.5 pphr
Zinc oxide lO pphr
Calcium carbonate 50 pphr Paraffinic oil 30 pphr
Ethyleneglycol dimethacrylate 45 pphr di-(tert-butyl-peroxy-isopropyl)benzene 4 pphr di-(tert-butyl-peroxy-trimethyl)-cyclohexane 4 pphr
Antimicrobial as noted
(INVENTIVE) EPDM BASE FORMULATION 6
Component Amount Ethylene-propylene diene modified Rubber 100 parts
Pentaerythritol tetrastearate (processing aid) 2 pphr
Blue organic pigment 2 pphr
Silica 50 pplrr
Stearic acid 0.5 pplrr Zinc oxide 5 pphr
Calcium carbonate 50 pphr
Paraffinic oil 50 pphr
Ethyleneglycol dimethacrylate 4 pphr di-(tert-butyl-peroxy-isopropyl)benzene 4 pphr di-(tert-butyl-peroxy-trimethyl)-cyclohexane 4 pphr
Antimicrobial as noted (INVENTIVE) NBR BASE FORMULATION 1
Component Amount
Acrylonitrile butadiene Rubber (from Zeon Chemicals) 100 parts
FEF N550 50 pphr
Stearic acid 1 pplrr
Microcrystalline wax 2 pphr
Polyethylene glycol 5 pphr
Silica 40 pphr
Zinc oxide 5 pphr
Calcium carbonate 20 pphr di-octyl-phthalate 3 pphr di-(tert-butyl-peroxy-isopropyl)benzene 4 pphr di-(tert-butyl-peroxy-trimethyl)-cyclohexane 4 pphr
Antimicrobial as noted
(INVENTIVE) NBR BASE FORMUL ATION 2
Component Amount
Acrylonitrile butadiene Rubber 100 parts
Pentaerythritol tetrastearate (processing aid) 1 pphr
Microcrystalline wax 1 pphr
FEF N550 50 pphr
Silica 20 pphr
Stearic acid 1 pphr
Zinc oxide 5 pphr
Calcium carbonate 20 pphr di-octyl-phthalate 20 pphr
Celogen® ADCK ( lowing agent) 3 pphr
Celogen® OB (Blowing agent) 3 pphr di-(tert-butyl-peroxy- •isopropyl)benzene 3 pplrr di-(tert-butyl-ρeroxy- •trimethyl)-cyclohexane 3 pphr
Antimicrobial as noted (INVENTIVE) NATURAL RUBBER BASE FORMULATION
Component Amount
Natural Rubber 100 parts
Pentaerythritol tetrastearate (processing aid) 2 pphr
Polyethylene glycol 5 pphr
Silica 40 pphr
Calcium oxide (dessicant) 10 pphr
Titanium dioxide 5 pphr
Zinc oxide 3 pphr
Calcium carbonate 20 pphr
Paraffinic oil 20 pphr
Ethyleneglycol dimethacrylate 2.5 pphr di-(tert-butyl-peroxy-isopropyl)benzene 1 pphr di-(tert-butyl-peroxy-trimethyl)-cyclohexane 1 pphr
Antimicrobial as noted
Specific samples with different silver ion-exchange zirconium phosphate salts (available from Milliken & Company under the tradename ALPHASAN®) were made from these base formulations and are listed below. The different biocides presented throughout are labeled in accordance with the following table:
TABLE Biocide Silver ion concentration Other components (% by weight) A 3.8% AgxNayHzZr2(PO4)3 where x+y+z=l B 10.0% AgχNayH2Zr2(PO )3 where x+y+z=l C 3.0% Zinc oxide (70%)(with 30% biocide B)
The compounding of ingredients within each formulation can be carried out in an open mill, an internal mixer, or an extruder where intensive mixing within the polymer matrix of each component will take place. During the mixing operation, the control of temperature rise, due to high shear incorporation of the ingredients, is crucial to ensure that pre- vulcanization (scorch) does not take place during processing. Generally, a maximum temperature of 120°C is reached on single stage (pass) mixing through an internal mixer. The compounds can be further processed after mixing into specific forms to allow adequate presentation for manufacturing into products. This could be calendering, extrusion, granulation/pelletization, strip form, fabrication and preforming into specific shaped blanks.
The vulcanization of the compounds can be in the form of molding (compression, transfer, injection), continuous extrusion (LCM, UHF[where permissible], autoclave and hot air), and coatings. The vulcanization (cure) temperatures can range from 150°C to 250°C. In this specific situation, the rubber articles were calendared into rough mat structures and then subjected to vulcanization under high temperature and pressure.
Testing of Vulcanized Rubber Articles
The following Tables list the antibacterial and antifungal activity of these inventive and comparative samples. The antimicrobial tests followed were AATCC Draft Test Method "Assessment of Antimicrobial Properties on Hydrophobic Textiles and Solid Substrates" and Japanese Method JIS2 2801 for Staphylococcus aureus and the antifungal tests followed were ISO 486 for Aspergillus niger and a mixture of fungi including Aspergillus niger, Paecilomyces variotii, and Trichoderma virens. Further tests, such as silver-ion extraction within an aqueous salt solution and testing the liquor for any extracted silver ions therein under inductively coupled plasma methods, were followed to analyze the effectiveness of certain additives (silica, carbon black, phthalate oils) in relation to antimicrobial efficacy as well. Lastly, industrial washing of such mats was undertaken in an effort to determine the improvements (if any) of the antimicrobial activity of certain samples.
EXPERIMENTAL TABLE 1
Antimicrobial Performance of rubber formulations for Staphylococcus aureus and Klebsiella pneumoniae
log kill reduction vs. internal control
Sample ID biocide ID S. aureus K. pneumoniae
EPDM Formulation 2 no biocide 0.66 1.35 EPDM Formulation 2 2% biocide B 3.27 5.21 EPDM Formulation 2 2% biocide C 3.27 5.21 EPDM Formulation 3 no biocide 0 -0.28 EPDM Formulation 3 2% biocide B 2.85 4.25 EPDM Formulation 4 no biocide 0 -0.21 EPDM Formulation 4 2% biocide B 2.85 4.25 NBR Formulation 1 no biocide NA 0 NBR Formulation 2 1% biocide A NA 3.87 NBR Formulation 1 1% biocide C NA 4.01 Natural Rubber Formulation no biocide NA -1.98 Natural Rubber Formulation 1 % biocide A NA -1.62 Natural Rubber Formulation 1% biocide C NA -1.19
Thus, the inventive formulations provided inventive vulcanized rubber articles that exhibited improved antimicrobial activity over the same formulations without any antimicrobial compounds present.
EXPERIMENTAL TABLE 2
Antifungal Performance of Inventive Rubber Articles
Fungal Gro\ vth After
0 5 10 15 20
EPDM no biocide Aspergillus niger 0 4 4 4 4 EPDM Formulation 5 Aspergillus niger 0 0 0 0 0 EPDM Formulation 6 Aspergillus niger 0 0 0 0 0 NBR Formulation 1 Aspergillus niger 0 0 0 0 0 EPDM no biocide mixture* 0 4 4 4 4
EPDM Formulation 5 mixture* 0 0 0 0 0 EPDM Formulation 6 mixture* 0 0 2 2 3 NBR Formulation 1 mixture* 0 0 1 2 3
Efficacy against fungi was assessed using ISO Method 846 against Aspergillus niger
ATCC 6275. The mixture of fungi includes Aspergillus niger ATCC 6275, Paecilomyces variotii ATCC 18502, Trichoderma virens ATCC 9645. Samples were placed on Potato Dextrose Agar (PDA) and inoculated with 10 droplets (lOul each, lOOul total) of 10E5 fungal spores/ml in a synthetic nutrient medium followed by incubation for 7-20 days at 30°C and >90% relative humidity. Efficacy was measured by visual observation of the samples. Observation Rating
None 0
Traces of Growth (less than 10%) 1
Light Growth (10-30%) 2 Medium Growth (30-60%) 3
Heavy Growth (60% to complete coverage) 4
EXPERIMENTAL TABLE 3
Antimicrobial Activity of inventive NBR formulation articles after industrial washing.
Sample ID biocide wash cycles K pneumoniae S. aureus
NBR Formulation 1 no biocide 0 wash -0.33 -0.10 NBR Formulation 1 no biocide 1 wash -0.72 -0.14
NBR Formulation 1 no biocide 20 wash -0.37 -0.09
NBR Formulation 1 1% biocide A 0 wash -0.01 0.16
NBR Formulation 1 1% biocide A 1 wash 3.67 2.17
NBR Formulation 1 1 % biocide A 20 wash 4.15 2.08 NBR Formulation 2 1.5% biocide A 0 wash -0.48 NA
NBR Formulation 2 1.5% biocide A 1 wash -0.56 NA
NBR Formulation 2 1.5% biocide A 20 wash 3.54 3.77
Thus, the inventive articles not only retained the antimicrobial and thus exhibited antimicrobial activity after washing, such activity actually and unexpectedly improved as the number of washes increased. This indicates that the amount of effective antimicrobial silver ions available at the target article surface increased as the number of washings increased. In fact, this was measured through silver ion extraction methods and found to be true for the above samples. The results are as follows:
EXPERIMENTAL TABLE 3 Antimicrobial Activity of inventive NBR formulation articles after industrial washing. Sample JD biocide wash cycles ppb of bio-available Ag+/cm2
NBR Formulation 1 no biocide 0 wash 0 NBR Formulation 1 no biocide 1 wash 0
NBR Formulation 1 no biocide 20 wash 0
NBR Formulation 1 1 % biocide A 0 wash 0.02
NBR Formulation 1 1%> biocide A 1 wash 0.7
NBR Formulation 1 1 % biocide A 20 wash 1.68 NBR Formulation 2 1.5% biocide A 0 wash 0.07
NBR Formulation 2 1.5% biocide A 1 wash 0.23
NBR Formulation 2 1.5% biocide A 20 wash 1.87 Antimicrobial Control Through Filler and Plasticizer Use as Well as Surface Abrasion
Of great interest and of highly unexpected nature, it was found that the amount of available antimicrobial present at the rubber article surface after initial production was greatly increased with the presence of certain fillers and oils within the rubber formulation. The affect of abrading the surface of one article through the contacting random portions of the target article surface with a sanding block for approximately 5 seconds is also shown. The target article was immersed in an aqueous salt extraction solution (sodium chloride) for 24 hours; the extract was then analyzed by inductively coupled plasma measurements for a measurement of available silver removed from the article surface. The following table illustrates these measurements:
EXPERIMENTAL TABLE 4
Example Surface Abraded? (Y/N) Available Ag+ ions (ppb/cm2)
■ EPDM Base Formulation 2 N 2.4 EPDM Base Formulation 3 N 0.41
EPDM Base Formulation 4 N 271.4
EPDM Base Formulation 4 Y 306.4
Thus, the inventive articles exhibited controlled release of silver ions dependent upon the presence of different fillers and oils, with the greatest increase occurring with the addition of silica and paraffinic oil with an even greater increase in potential antimicrobial efficacy through the utilization of an abrasion procedure to the article surface.
Having described the invention in detail it is obvious that one skilled in the art will be able to make variations and modifications thereto without departing from the scope of the present invention. Accordingly, the scope of the present invention should be determined only by the claims appended hereto.

Claims

1. A pre-vulcanized rubber formulation comprising at least one rubber constituent, the majority of which must be a non-silicone rubber, at least one silver-based antimicrobial compound, and at least one curing compound, wherein all of said curing compounds present within said formulation does not include an appreciable amount of sulfur-based compounds; wherein said rubber formulation optionally comprises at least one blowing agent, at least one silver ion release control additive, and at least one antifungal additive other than said silver- based antimicrobial compound.
2. The rubber formulation of Claim 1 wherein said rubber constituent is selected from the group consisting of ethylene-propylene diene monomer (EPDM) rubber, nitrile butadiene rubber (NBR), natural rubber, and any mixture thereof.
3. The rubber formulation of Claim 1 wherein said silver-based antimicrobial compound is selected from the group consisting of elemental silver, silver oxides, silver salts, silver ion exchange compounds, silver zeolites, silver glasses, and any mixtures thereof.
4. The rubber formulation of Claim 2 wherein said silver-based antimicrobial compound is selected from the group consisting of elemental silver, silver oxides, silver salts, silver ion exchange compounds, silver zeolites, silver glasses, and any mixtures thereof.
5. The rubber formulation of Claim 1 wherein said curing compound comprises a majority amount by weight of at least one peroxide.
6. The rubber formulation of Claim 5 wherein said peroxide is an organic peroxide.
7. The rubber formulation of Claim 2 wherein said curing compound comprises a majority amount by weight of at least one peroxide.
8. The rubber formulation of Claim 7 wherein said peroxide is an organic peroxide.
9. The rubber formulation of Claim 3 wherein said curing compound comprises a majority amount by weight of at least one peroxide.
10. The rubber formulation of Claim 9 wherein said peroxide is an organic peroxide.
11. The rubber formulation of Claim 4 wherein said curing compound comprises a majority amount by weight of at least one peroxide.
12. The rubber formulation of Claim 11 wherein said peroxide is an organic peroxide.
13. The rubber formulation of Claim 1 wherein said at least one blowing agent is present.
14. The rubber formulation of Claim 1 wherein said at least one silver ion control release additive is present.
15. The rubber formulation of Claim 1 wherein said antifungal additive other than said silver-based antimicrobial compound is present.
16. The rubber formulation of Claim 14 where said at least one silver ion control release additive is selected from the group consisting of fillers, oils, pigments, salts, antistatic agents, and any mixtures thereof.
17. The rubber formulation of Claim 16 wherein said at least one silver ion control release additive is a hydrophilic filler selected from the group consisting of silica, stearates, and any mixtures thereof.
18. The rubber formulation of Claim 16 further comprising at least one oil selected from the group consisting of paraffinic oil, phthalate oil, and any mixtures thereof.
19. The rubber formulation of Claim 2 wherein said rubber constituent is EPDM.
20. The rubber formulation of Claim 2 wherein said rubber constituent is NBR.
21. The rubber formulation of Claim 2 wherein said rubber constituent is natural rubber.
22. A method of producing a rubber article exhibiting long-lasting, regenerable antimicrobial characteristics, comprising the steps of compounding together the unvulcanized rubber formulation of Claim 1, molding said rubber formulation into a preselected shape, and vulcanizing said rubber formulation under high pressure and exposure to high temperature.
23. A method of producing a rubber article exhibiting long-lasting, regenerable antimicrobial characteristics, comprising the steps of compounding together the unvulcanized rubber formulation of Claim 2, molding said rubber formulation into a preselected shape, and vulcanizing said rubber formulation under high pressure and exposure to high temperature.
24. A method of producing a rubber article exhibiting long-lasting, regenerable antimicrobial characteristics, comprising the steps of compounding together the unvulcanized rubber formulation of Claim 13, molding said rubber formulation into a preselected shape, and vulcanizing said rubber formulation under high pressure and exposure to high temperature.
25. A method of producing a rubber article exhibiting long-lasting, regenerable antimicrobial characteristics, comprising the steps of compounding together the unvulcanized rubber formulation of Claim 14, molding said rubber formulation into a preselected shape, and vulcanizing said rubber formulation under high pressure and exposure to high temperature.
26. A method of producing a rubber article exhibiting long-lasting, regenerable antimicrobial characteristics, comprising the steps of compounding together the unvulcanized rubber foπnulation of Claim 15, molding said rubber formulation into a preselected shape, and vulcanizing said rubber formulation under high pressure and exposure to high temperature.
27. A rubber composition comprising at least one rubber component, at least one peroxide curing agent, and at least one silver-based antimicrobial agent, and optionally comprising at least one blowing agent, at least one silver ion release control additive, and at least one antifungal additive other than said silver-based antimicrobial compound.
28. A dimensionally stable vulcanized rubber article comprising at least one silver-based antimicrobial agent, wherein said rubber article exhibits log kill rates in accordance with the
AATCC Draft Method entitled "Assessment of Antimicrobial Properties on Hydrophobic Textiles and Solid Substrates" for Staphylococcus aureus and Klebsiella pneumoniae of at least 1.0 each after 24 hours exposure at room temperature, and wherein said article optionally comprises at least one silver ion release control additive, and at least one antifungal additive other than said silver-based antimicrobial compound.
29. The rubber article of Claim 28 wherein said article exhibits log kill rates for Staphylococcus aureus and Klebsiella pneumoniae of at least 2.0 each after 24 hours exposure at room temperature.
30. The rubber article of Claim 28 wherein said silver-based antimicrobial compound is selected from the group consisting of elemental silver, silver oxides, silver salts, silver ion exchange compounds, silver zeolites, silver glasses, and any mixtures thereof.
31. The rubber article of Claim 29 wherein said silver-based antimicrobial compound is selected from the group consisting of elemental silver, silver oxides, silver salts, silver ion exchange compounds, silver zeolites, silver glasses, and any mixtures thereof.
32. The rubber article of Claim 28 wherein said at least one silver ion control release additive is present.
33. The rubber article of Claim 28 wherein said antifungal additive other than said silver-based antimicrobial compound is present.
34. The rubber article of Claim 32 where said at least one silver ion control release additive is selected from the group consisting of fillers, oils, pigments, salts, antistatic agents, and any mixtures thereof.
35. The rubber article of Claim 34 wherein said at least one silver ion control release additive is a hydrophilic filler selected from the group consisting of silica, stearates, and any mixtures thereof.
36. The rubber article of Claim 35 further comprising at least one hydrophilic oil selected from the group consisting of paraffinic oil, phthalate oil, and any mixtures thereof.
37. The rubber article of Claim 28 wherein said rubber comprises a majority of a component selected from the group consisting of EPDM, NBR, natural rubber, and any mixtures thereof.
38. A dimensionally stable vulcanized rubber-containing article comprising at least one silver-based antimicrobial agent, wherein said article exhibits antifungal properties such that said article exhibits at least 70% inhibition in accordance with Test Method ISO 486 of Aspergillus niger ATCC 6275 for at least 15 days at 30°C and at greater than 90% humidity, wherein said article optionally comprises at least one silver ion release control additive, and at least one antifungal additive other than said silver-based antimicrobial compound.
39. The rubber article of Claim 38 wherein said silver-based antimicrobial compound is selected from the group consisting of elemental silver, silver oxides, silver salts, silver ion exchange compounds, silver zeolites, silver glasses, and any mixtures thereof.
40. The rubber article of Claim 38 wherein said at least one silver ion control release additive is present.
41. The rubber article of Claim 38 wherein said antifungal additive other than said silver-based antimicrobial compound is present.
42. The rubber article of Claim 40 where said at least one silver ion control release additive is selected from the group consisting of fillers, oils, pigments, salts, antistatic agents, and any mixtures thereof.
43. The rubber article of Claim 42 wherein said at least one silver ion control release additive is a hydrophilic filler selected from the group consisting of silica, stearates, and any mixtures thereof.
44. The rubber article of Claim 43 further comprising at least one hydrophilic oil selected from the group consisting of paraffinic oil, phthalate oil, and any mixtures thereof.
45. The rubber article of Claim 38 wherein said rubber comprises a majority of a component selected from the group consisting of EPDM, NBR, natural rubber, and any mixtures thereof.
46. The rubber article of Claim 1 wherein said article is a mat structure.
47. The rubber article of Claim 28 wherein said article is a mat structure.
48. The rubber article of Claim 38 wherein said article is a mat structure.
EP02753761A 2001-03-23 2002-03-01 Antimicrobial rubber compositions Withdrawn EP1381644A4 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US815483 1986-01-02
US815730 1991-12-30
US09/815,730 US6455610B1 (en) 2001-03-23 2001-03-23 Antimicrobial pre-vulcanized rubber compositions
US815637 2001-03-23
US09/815,637 US6448306B1 (en) 2001-03-23 2001-03-23 Antimicrobial articles made from nitrile or natural rubber
US09/815,483 US6555599B2 (en) 2001-03-26 2001-03-26 Antimicrobial vulcanized EPDM rubber articles
PCT/US2002/006422 WO2002077095A2 (en) 2001-03-23 2002-03-01 Antimicrobial rubber compositions

Publications (2)

Publication Number Publication Date
EP1381644A2 true EP1381644A2 (en) 2004-01-21
EP1381644A4 EP1381644A4 (en) 2005-11-02

Family

ID=27420106

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02753761A Withdrawn EP1381644A4 (en) 2001-03-23 2002-03-01 Antimicrobial rubber compositions

Country Status (6)

Country Link
EP (1) EP1381644A4 (en)
JP (1) JP4180922B2 (en)
CN (1) CN1303142C (en)
AU (1) AU2002306639A1 (en)
BR (1) BR0208344A (en)
WO (1) WO2002077095A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8317861B2 (en) 2001-04-11 2012-11-27 Helix Medical, Llc Antimicrobial indwelling voice prosthesis
US7520897B2 (en) 2001-04-11 2009-04-21 Helix Medical, Llc Medical devices having antimicrobial properties
US6638993B2 (en) * 2001-12-12 2003-10-28 Milliken & Company Colored antimicrobial vulcanized rubber articles
WO2004096902A2 (en) * 2003-04-25 2004-11-11 Milliken & Company Antimicrobial pre-vulcanized rubber compositions and antimicrobial vuclanized rubber articles
KR100767593B1 (en) 2004-09-13 2007-10-17 조위수 Manufacturing method of toe pressure implement
US7858674B2 (en) * 2007-02-05 2010-12-28 Milliken & Co. Antimicrobial rubber formulations and molded article
JP5674684B2 (en) 2009-02-03 2015-02-25 マイクロビオン コーポレーション Bismuth-thiol as a disinfectant for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
US9408393B2 (en) 2010-02-03 2016-08-09 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
CN103289408A (en) * 2012-02-29 2013-09-11 刘芳 Method for preparing silicon rubber
CN103709524A (en) * 2013-12-16 2014-04-09 芜湖万润机械有限责任公司 Antibacterial rubber apron
CN104109332A (en) * 2014-07-03 2014-10-22 深圳市沃特新材料股份有限公司 Antimicrobial thermoplastic elastomer, and preparation method and application thereof
CN105061906A (en) * 2015-07-23 2015-11-18 韦海棉 EPDM (ethylene-propylene-diene monomer) foaming material and preparation method therefor
CN105348603A (en) * 2015-11-09 2016-02-24 安徽冠泓塑业有限公司 Anti-wrinkling auxiliary agent for household cleaning glove processing
CN105801938B (en) * 2016-04-12 2018-01-09 盐城市合荣文体用品有限公司 A kind of environmentally friendly erasing rubber with antibacterial functions and preparation method thereof
CN106146960A (en) * 2016-08-31 2016-11-23 湖北孺子牛鞋业集团有限公司 A kind of preparation method of vapor-permeable type antibacterial sponge
CN112804878A (en) 2018-07-31 2021-05-14 微生物公司 Bismuth-thiol compositions and methods of use
EP3829299A4 (en) 2018-07-31 2022-04-13 Microbion Corporation Bismuth-thiol compositions and methods for treating wounds
CN111019255A (en) * 2019-12-31 2020-04-17 东莞市特谱峰实业有限公司 Antibacterial rubber material and preparation method thereof
CN111873716A (en) * 2020-08-05 2020-11-03 江苏中鸿坦达橡胶科技有限公司 Integrated vulcanized non-pneumatic tire without steel wires and cord fabric
CN112126138A (en) * 2020-08-07 2020-12-25 山东玲珑轮胎股份有限公司 Antibacterial rubber composition and tire
CN111944215A (en) * 2020-09-09 2020-11-17 河北九度橡胶科技有限公司 Rubber antibacterial chopping board and preparation method thereof
CN112111117B (en) * 2020-10-12 2022-06-14 新疆农业大学 Environment-friendly wood-plastic composite material treated by microorganisms, and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3427264A (en) * 1966-02-07 1969-02-11 Exxon Research Engineering Co Metal-filled plastics comprising a styrene polymer and an elastomer
US4252692A (en) * 1972-09-01 1981-02-24 Raychem Limited Materials having non-linear electrical resistance characteristics
EP0361506A2 (en) * 1988-09-30 1990-04-04 Daikin Industries, Limited Crosslinkable composition of fluorine-containing elastomer
US5736591A (en) * 1996-03-01 1998-04-07 The Goodyear Tire & Rubber Co. Latex with resistance to bacterial growth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334311C (en) * 1986-10-29 1995-02-07 Mitsui Chemicals, Incorporated Thermoplastic elastomer composition excellent in heat bondability
JPH07194661A (en) * 1993-12-29 1995-08-01 Sanpo Bussan Kk Production of antibacterial rubber mat
DE69507067T2 (en) * 1994-04-14 1999-08-05 Mitsui Chemicals Inc Process for the production of high molecular weight acrylamide polymers
JPH08239577A (en) * 1995-02-28 1996-09-17 Toray Dow Corning Silicone Co Ltd Antimicorbial silicone rubber composition
JPH09176495A (en) * 1995-12-28 1997-07-08 Furukawa Electric Co Ltd:The Outdoor insulating polymer material composition and outdoor high voltage instrument
US6332293B1 (en) * 1997-02-28 2001-12-25 Milliken & Company Floor mat having antimicrobial characteristics
JPH11158328A (en) * 1997-11-27 1999-06-15 Fujikura Rubber Ltd Antibacterial rubber part

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3427264A (en) * 1966-02-07 1969-02-11 Exxon Research Engineering Co Metal-filled plastics comprising a styrene polymer and an elastomer
US4252692A (en) * 1972-09-01 1981-02-24 Raychem Limited Materials having non-linear electrical resistance characteristics
EP0361506A2 (en) * 1988-09-30 1990-04-04 Daikin Industries, Limited Crosslinkable composition of fluorine-containing elastomer
US5736591A (en) * 1996-03-01 1998-04-07 The Goodyear Tire & Rubber Co. Latex with resistance to bacterial growth

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 131, no. 20060, 18 June 1999 (1999-06-18), Columbus, Ohio, US; abstract no.: 1999:378220, *
DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 18 June 1999 (1999-06-18), MIKI, SHIGEKI ET AL: "Antibacterial rubber parts for use in contact with drinking water" XP002343598 retrieved from STN Database accession no. 1999:378584 -& JP 11 158328 A (FUJIKURA RUBBER WORKS, LTD., JAPAN) 15 June 1999 (1999-06-15) *
DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 4 September 1997 (1997-09-04), SHINKOTANI, NOBUHIRO ET AL: "Tracking-resistant electrically insulating polymer compositions for outdoors with good resistance to moss and fungi and high-voltage outdoor electric machineries therefrom" XP002343597 retrieved from STN Database accession no. 1997:558752 -& JP 09 176495 A (FURUKAWA ELECTRIC CO., LTD., JAPAN) 8 July 1997 (1997-07-08) *
DATABASE WPI Section Ch, Week 199539 Derwent Publications Ltd., London, GB; Class A97, AN 1995-298185 XP002343671 -& JP 07 194661 A (KURARAY CO LTD) 1 August 1995 (1995-08-01) *
See also references of WO02077095A2 *

Also Published As

Publication number Publication date
JP4180922B2 (en) 2008-11-12
WO2002077095A2 (en) 2002-10-03
CN1303142C (en) 2007-03-07
EP1381644A4 (en) 2005-11-02
AU2002306639A1 (en) 2002-10-08
BR0208344A (en) 2004-08-24
CN1498243A (en) 2004-05-19
WO2002077095A3 (en) 2003-02-27
JP2004526029A (en) 2004-08-26

Similar Documents

Publication Publication Date Title
US6846871B2 (en) Antimicrobial resin cured rubber articles and prevulcanized compositions
US6555599B2 (en) Antimicrobial vulcanized EPDM rubber articles
US6448306B1 (en) Antimicrobial articles made from nitrile or natural rubber
US7060739B2 (en) Antimicrobial fluoroelastomer rubber articles and compositions
US6455610B1 (en) Antimicrobial pre-vulcanized rubber compositions
WO2002077095A2 (en) Antimicrobial rubber compositions
US6638993B2 (en) Colored antimicrobial vulcanized rubber articles
US6852782B2 (en) Antimicrobial articles and compositions made from non-silicone vulcanized rubber
US7858674B2 (en) Antimicrobial rubber formulations and molded article
US6943205B2 (en) Antimicrobial articles and compositions made from styrene butadiene rubber
US20110233810A1 (en) Antimicrobial plastic compositions and methods for preparing same
JP2004526029A5 (en)
EP1618144A2 (en) Antimicrobial pre-vulcanized rubber compositions and antimicrobial vuclanized rubber articles
Zander et al. Microbial susceptibility of various polymers and evaluation of thermoplastic elastomers with antimicrobial additives
Iyigundogdu et al. Thermoplastic elastomers containing antimicrobial and antiviral additives for mobility applications
US20080248076A1 (en) Antimicrobial rubber bands
KR100665719B1 (en) Method for produce of Rubber gloves contain Nano silver
JP2006524740A5 (en)
KR20060113154A (en) Rubber gloves contained aluminium hydroxide-manganese nano mixture and process for preparation of the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030919

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 08K 5/14 B

Ipc: 7C 08K 5/00 B

Ipc: 7C 08K 3/34 B

Ipc: 7C 08K 3/10 B

Ipc: 7C 08K 3/08 B

Ipc: 7C 08K 3/00 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050919

17Q First examination report despatched

Effective date: 20060322

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100609